Professor, Internal Medicine, Yale University School of Medicine
Internal Medicine
Dr. David A. Fiellin, MD
|
|
Give Review
Dr. David A. Fiellin works in the field of Internal Medicine. He went to Emory University School of Medicine. Emory University School of Medicine is ranked 23/42 in Research/PrimaryCare. David Fiellin is a published doctor and has 99 publications published. The lastest was: 'Estimating demand for primary care-based treatment for substance and alcohol use disorders.' He is registered with Medicare and accepts Medicare payments.
Publications
- Estimating demand for primary care-based treatment for substance and alcohol use disorders.
- Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men.
- Drinking trajectories among HIV-infected men who have sex with men: A cohort study of United States veterans.
- Prevalence and correlates of obstructive sleep apnoea among patients with and without HIV infection.
- Incarceration and health outcomes in HIV-infected patients: The impact of substance use, primary care engagement, and antiretroviral adherence.
- Addressing bias in observational studies of alcohol withdrawal syndrome: a call to the field.
- Alcohol-Related Diagnoses and All-Cause Hospitalization Among HIV-Infected and Uninfected Patients: A Longitudinal Analysis of United States Veterans from 1997 to 2011.
- Guideline-concordant management of opioid therapy among human immunodeficiency virus (HIV)-infected and uninfected veterans.
- The impact of recent cocaine use on plasma levels of methadone and buprenorphine in patients with and without HIV-infection.
- Primary Care-Based Buprenorphine Taper vs Maintenance Therapy for Prescription Opioid Dependence: A Randomized Clinical Trial.
- Buprenorphine/Naloxone Dose and Pain Intensity Among Individuals Initiating Treatment for Opioid Use Disorder.
- Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: Implications for clinical use and policy.
- Reply to: High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/HCV-coinfected patients: a gender analysis using transient elastogra...
- Source of prescription drugs used nonmedically in rural and urban populations.
- Sexual Partner Notification of HIV Infection Among a National United States-Based Sample of HIV-Infected Men.
- Increased Hospital and Emergency Department Utilization by Individuals with Recent Criminal Justice Involvement: Results of a National Survey.
- Substance use in older HIV-infected patients.
- The impact of buprenorphine/naloxone treatment on HIV risk behaviors among HIV-infected, opioid-dependent patients.
- Relationship Between Alcohol Use Categories and Noninvasive Markers of Advanced Hepatic Fibrosis in HIV-Infected, Chronic Hepatitis C Virus-Infected, and Uninfected Pa...
- The effects of federal parity on substance use disorder treatment.
- Acetaminophen receipt among HIV-infected patients with advanced hepatic fibrosis.
- Racial/ethnic differences in report of drug testing practices at the workplace level in the U.S.
- The Next Therapeutic Challenge in HIV: Polypharmacy.
- Sex disparities in overall burden of disease among HIV-infected individuals in the Veterans Affairs healthcare system.
- Effects of federal parity on substance use disorder treatment.
- Pain and Associated Substance Use among Opioid Dependent Individuals Seeking Office-Based Treatment with Buprenorphine-Naloxone: A Needs Assessment Study.
- Measuring Alcohol Consumption Using Timeline Followback in Non-Treatment-Seeking Medical Clinic Patients With and Without HIV Infection: 7-, 14-, or 30-day Recall.
- A Research Agenda for Enhancing Appropriate Opioid Prescribing in Primary Care.
- Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: A systematic review.
- Hazardous drinking and its association with homelessness among veterans in care.
- Agreement between electronic medical record-based and self-administered pain numeric rating scale: clinical and research implications.
- Comparing Alcohol Screening Measures Among HIV-Infected and -Uninfected Men.
- Physician detection of unhealthy substance use on inpatient teaching and hospitalist medical services.
- Previous use of alcohol, cigarettes, and marijuana and subsequent abuse of prescription opioids in young adults.
- The Recovery Line: A pilot trial of automated, telephone-based treatment for continued drug use in methadone maintenance.
- A randomized trial of cognitive behavioral therapy in primary care-based buprenorphine.
- Moving HIV pre-exposure prophylaxis into clinical settings: lessons from buprenorphine.
- Antiretroviral Adherence Among Rural Compared to Urban Veterans with HIV Infection in the United States.
- Receipt of opioid analgesics by HIV-infected and uninfected patients.
- Development of a scale to measure practitioner adherence to a brief intervention in the emergency department.
- Prevalence and correlates for nonmedical use of prescription opioids among urban and rural residents.
- Unhealthy Alcohol and Illicit Drug Use are Associated with Decreased Quality of HIV Care.
- Combining Rapid HIV Testing and a Brief Alcohol Intervention in Young Unhealthy Drinkers in the Emergency Department: A Pilot Study.
- Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment.
- Screening, Brief Intervention, and Referral to Treatment (SBIRT) for Alcohol and Other Drug Use Among Adolescents: Evaluation of a Pediatric Residency Curriculum.
- Human Immunodeficiency Virus Testing Practices Among Buprenorphine-prescribing Physicians.
- Developing and Implementing a Multispecialty Graduate Medical Education Curriculum on Screening, Brief Intervention, and Referral to Treatment (SBIRT).
- Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV?
- Current and Potential Pharmacological Treatment Options for Maintenance Therapy in Opioid-Dependent Individuals.
- Cost-Effectiveness of Long-Term Outpatient Buprenorphine-Naloxone Treatment for Opioid Dependence in Primary Care.
- Reply to Letter "Additional Explanation for Lack of Pharmacodynamic Interaction Between Atazanavir and Buprenorphine Reported by Vergara-Rodriquez et al"
- Adjunctive Counseling During Brief and Extended Buprenorphine-Naloxone Treatment for Prescription Opioid Dependence: A 2-Phase Randomized Controlled Trial.
- State Variation in AIDS Drug Assistance Program Prescription Drug Coverage for Modifiable Cardiovascular Risk Factors.
- Nonmedical use of opioid analgesics obtained directly from physicians: prevalence and correlates.
- Cost and utilization outcomes of opioid-dependence treatments.
- The BHIVES collaborative: organization and evaluation of a multisite demonstration of integrated buprenorphine/naloxone and HIV treatment.
- Alcohol consumption and depressive symptoms over time: A longitudinal study of patients with and without HIV infection.
- Opioids, chronic pain, and addiction in primary care.
- The case for routine HIV screening and impact of managed care.
- The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand/improve buprenorphine treatment.
- Evaluating interventions to improve antiretroviral adherence: how much of an effect is required for favorable value?
- Opioid doses and increased risk for overdose.
- Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone.
- Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial.
- Depression symptoms and treatment among HIV infected and uninfected veterans.
- Erectile dysfunction drug receipt, risky sexual behavior and sexually transmitted diseases in HIV-infected and HIV-uninfected men.
- The association between chronic pain and prescription drug abuse in Veterans.
- Integrating buprenorphine treatment into office-based practice: a qualitative study.
- Treatment of adolescent opioid dependence: no quick fix.
- Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.
- Brief intervention for hazardous and harmful drinkers in the emergency department.
- Narrative review: buprenorphine for opioid-dependent patients in office practice.
- Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years.
- Utility of sweat patch testing for drug use monitoring in outpatient treatment for opiate dependence.
- The first three years of buprenorphine in the United States: experience to date and future directions.
- Women and opioid dependence treatment: office-based versus opioid treatment program-based care?
- Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients.
- Effects of marijuana smoking on pulmonary function and respiratory complications: a systematic review.
- Patient satisfaction with primary care office-based buprenorphine/naloxone treatment.
- Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction.
- Opioid dependence: rationale for and efficacy of existing and new treatments.
- A trial of integrated buprenorphine/naloxone and HIV clinical care.
- Initial strategies for integrating buprenorphine into HIV care settings in the United States.
- A randomized trial of primary intensive care to reduce hospital admissions in patients with high utilization of inpatient services.
- Training HIV physicians to prescribe buprenorphine for opioid dependence.
- Evaluation of a combined online and in person training in the use of buprenorphine.
- Mental health after deployment to Iraq or Afghanistan.
- Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veterans.
- Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.
- The association between marijuana smoking and lung cancer: a systematic review.
- Buprenorphine: effective treatment of opioid addiction starts in the office.
- Quality of care for acute myocardial infarction in elderly patients with alcohol-related diagnoses.
- Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence.
- Primary intensive care: pilot study of a primary care-based intervention for high-utilizing patients.
- The prevalence and impact of alcohol problems in major depression: a systematic review.
- Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency department.
- Provider satisfaction with office-based treatment of opioid dependence: a systematic review.
- An evidence-based guide to writing grant proposals for clinical research.
Schools
Emory University
Yale New Haven Hospital
Yale University
Doctors Specialties
- Internal Medicine
Accepted Insurances
Education
-
Yale-New Haven Hospital -
Emory University School of Medicine
Drug Facts
| NPI NUMBER | 1194700666 | |
| NPPES Provider LastName | FIELLIN | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 065191304 | |
| NPPES Provider State | CT | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 446.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1194700666 |
| Last Name Of The Provider | FIELLIN |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Le Q. Vo, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Crystal M. Ritsema, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alice C. Li, MD |
|
|
Dr. Rafael Y. Lefkowitz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paul Genecin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elizabeth A. Heuzey, MD |
|
|
Muhammad S. Mansoor, MB BS
This Doctor is OpenDoctor Recommended.
|